Company intelligence / Profile preview

Vitabalans

Hämeenlinna, Häme, Finlandvitabalans.fi ↗

Ownership: Private
Employees: ~240
Development stage: Other

Overview

Vitabalans Oy develops, manufactures, and markets a broad range of prescription and over-the-counter medicines as well as food supplements, medical devices, probiotic products, and animal health products. The company’s strengths include the development and manufacture of medicines targeting pain relief, allergy management, cardiovascular diseases, and insomnia. All R&D and manufacturing take place at their GMP-certified facilities in Hämeenlinna, Finland. Their portfolio includes both human health products and special animal feeds. They export to several countries with sales organizations across Europe.

Therapeutic areas: PsychiatryImmunologyNeurologyCardiovascular
Modalities: Small moleculeLive biotherapeutic product therapyMedical deviceProteinPeptides
Industry: Biotech

Partnerships

UltraPharma (resales/logistics in GCC region & Singapore)

Beyond the preview

Go deeper on Vitabalans.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitabalans.

Explore the full profile